Singapore markets open in 45 minutes

Straits Times Index
3,292.69
+10.64(+0.32%)
S&P 500
5,018.39
-17.30(-0.34%)
Dow
37,903.29
+87.37(+0.23%)
Nasdaq
15,605.48
-52.34(-0.33%)
Bitcoin USD
58,315.19
-2,336.66(-3.85%)
CMC Crypto 200
1,277.92
-61.15(-4.57%)

Nektar Therapeutics (NKTR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

1.6500

+0.1900

(+13.01%)

At close: 04:00PM EDT

1.7000

+0.05

(+3.03%)

After hours:

07:51PM EDT

Loading interactive chart…

Zacks
Nektar (NKTR) Up 7.5% Since Last Earnings Report: Can It Continue?
Nektar (NKTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR Newswire
Nektar Management to Present at the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
Nektar Therapeutics (Nasdaq: NKTR) management is scheduled to present at the upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference on Thursday, March 28, 2024 at 1:30 p.m. Eastern Time / 10:30 a.m. Pacific Time.
Zacks
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
The placebo-controlled, phase IIb study will investigate the efficacy and safety of Nektar's (NKTR) rezpeg in patients with severe to very severe alopecia areata.